Pregled bibliografske jedinice broj: 550502
The onset of brain insulin dysfunction following the streptozotocin central application in rat
The onset of brain insulin dysfunction following the streptozotocin central application in rat // Periodicum biologorum
Zagreb, 2010. str. 90-90 (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 550502 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The onset of brain insulin dysfunction following the streptozotocin central application in rat
Autori
Knezović, Ana ; Marjanović, Ana Marija ; Osmanović-Barilar, Jelena ; Riederer, Peter ; Šalković-Petrišić, Melita
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Periodicum biologorum
/ - Zagreb, 2010, 90-90
Skup
6th Croatian Congress of Pharmacology with International Participation
Mjesto i datum
Opatija, Hrvatska, 15.09.2010. - 18.09.2010
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
insulin receptor; streptozotocin; cognition; Alzheimer's disease
Sažetak
Introduction: A growing body of evidence indicates that impairments in brain insulin signalling have important role in early sporadic Alzheimer’s disease (sAD) but their onset in relation to the cognitive impairment has not been clarified. Recently, brain insulin dysfunction was found also in streptozotocin (STZ)-intracerebroventricularly (icv) treated rats, which represent experimental model of sAD, suitable for determining this neurochemical - cognitive impairment causal relationship. Materials and methods: Male Wistar rats (three months old) were injected with STZ (3mg/kg) bilaterally into the lateral ventricles. Control animals were injected icv with vehicle only. Cognitive functions were tested by Morris Water Maze Swimming Test before sacrifice, two weeks and one month following the STZ-icv treatment, respectively. Protein expression of insulin receptor (IR), insulin-degrading enzyme (IDE) and protein kinase B (Akt/PKB) in hippocampus (HPC) was measured by SDS-PAGE electrophoresis, followed by Western blot analysis. Data were analysed by Mann-Whitney U test (p<0.05). Results: Deficit in learning and memory, found two weeks following the STZ-icv treatment (-33%) in comparison to the controls, demonstrated further deterioration as measured 1 month following the STZ-icv application (-54%). However, in spite of that, no change in protein expression of IR, Akt/PKB and IDE in HPC could have been observed two weeks following the STZ-icv application, in comparison to the control rats, while significantly decreased expression of IR (- 19.5%) and IDE (-55%) was found after one month. Akt/PKB protein expression remained unchanged. Conclusion: Results suggest that in respect to the hippocampal protein expression of IR, Akt/PKB and IDE, STZ-icv induced deficit in learning and memory seems to appear earlier than neurochemical manifestation of brain insulin system dysfunction in rats. Acknowledgement: Supported by MZOŠ (108- 1080003-0020) and DAAD projects.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
108-1080003-0020 - Mozak, eksperimentalni i cerebralni dijabetes i kognitivni i drugi poremećaji (Šalković-Petrišić, Melita, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Melita Šalković-Petrišić
(autor)
Ana Knezović
(autor)
Ana Marija Marjanović Čermak
(autor)
Jelena Osmanović
(autor)